Related Experiment Video
Updated: Aug 11, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Oxygen and retinopathy of prematurity
1Department of Pediatric Research, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway. o.d.saugstad@medisin.uio.no
Insights
Strictly controlling oxygen levels (SaO2) in premature infants can prevent severe retinopathy of prematurity. Avoiding hyperoxia and fluctuations is key to managing this blinding eye condition.
Area of Science:
- Neonatal ophthalmology
- Perinatal medicine
- Vascular biology
Background:
- Retinopathy of prematurity (ROP) is a growing global health concern, causing blindness in 50,000 children annually.
- Recent research clarifies the roles of hyperoxia, low gestational age, growth factors, and oxidative stress in ROP pathogenesis.
- Understanding ROP mechanisms is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To elucidate the complex interplay of factors contributing to retinopathy of prematurity.
- To highlight the critical role of oxygen management in preventing severe ROP.
- To inform potential therapeutic interventions based on current understanding.
Main Methods:
- Review of current research on retinopathy of prematurity.
- Analysis of the phases of ROP development, including vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) dynamics.
- Examination of the impact of hyperoxia on ROP progression.
Main Results:
- Hyperoxia initially inhibits VEGF, followed by a surge in VEGF and IGF-1, potentially leading to neovascularization around 32-34 weeks postconceptional age.
- Strict avoidance of hyperoxia (SaO2 > 92-93%) and oxygen saturation fluctuations can prevent severe ROP.
- The precise therapeutic implications of these findings remain under investigation.
Conclusions:
- Managing oxygenation is paramount in preventing severe retinopathy of prematurity.
- Maintaining stable, appropriate oxygen saturation levels in premature infants is an effective preventative measure.
- Further research is needed to translate these insights into novel therapies for ROP.
Abstract:
Retinopathy of prematurity is on the rise and a third epidemic has been identified. In spite of extensive research and progress in the understanding of this disease in recent years, 50 000 children worldwide are blinded by this condition each year. The relation between hyperoxia, low-gestational age, growth retardation, oxygen dependent growth factors, and oxidative stress are now being understood more clearly. We know that in the first phase of retinopathy of prematurity, hyperoxia inhibits vascular endothelial growth factor. In the second phase, vascular endothelial growth factor rises, and when insulin-like growth factor-1 reaches a threshold around 32 to 34 weeks postconceptional age, uncontrolled neovascularization may occur. It is not known whether this new knowledge will have implications for future therapy. However, by strictly avoiding hyperoxia, that is, SaO2>92-93% and avoiding fluctuations in SaO2, it is possible to control and prevent severe retinopathy of prematurity in most cases.
Related Concept Videos
Diabetic Retinopathy
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Oxygen Transport in the Blood
Photoreceptors and Visual Pathways

